These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1121805)

  • 21. [Pathogenesis of leukopenia in systemic lupus erythematosus (I). Effect of prednisolone on colony forming units in culture (CFU-C) growth in patients with systemic lupus erythematosus (SLE)].
    Sugimoto M; Wakabayashi Y; Shiokawa Y; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1982 May; 45(3):594-9. PubMed ID: 7136458
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of azathioprine and prednisolone on T- and B-lymphocytes in patients with lupus nephritis and chronic glomerulonephritis.
    Tareyeva IE; Shilov EM; Gordovskaya NB
    Clin Nephrol; 1980 Nov; 14(5):233-7. PubMed ID: 6971722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of peripheral blood lymphocytes from systemic lupus erythematosus patients on human bone marrow granulocyte precursor cells (colony-forming units in culture).
    Sugimoto M; Wakabayashi Y; Shiokawa Y; Takaku F
    Stem Cells (1981); 1982; 2(3):164-76. PubMed ID: 7163917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fulminant pneumonitis developed during the middle-dose corticosteroid therapy in systemic lupus erythematosus.
    Oku H; Okamura M; Amatsu K; Ohe A; Kato N; Kanayama Y; Horiguchi T; Inoue T
    Osaka City Med J; 1980; 26(2):145-9. PubMed ID: 7290651
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of the preparation essentiale in the therapy of lupus erythematosus].
    Glavinskaia TA; Novikov AI; Pavlova LT
    Vestn Dermatol Venerol; 1983 May; (5):4-7. PubMed ID: 6880388
    [No Abstract]   [Full Text] [Related]  

  • 26. Long term use of piroxicam in the treatment of systemic lupus erythematosus.
    Gergely P
    Ther Hung; 1991; 39(1):16-8. PubMed ID: 1858070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus].
    Arshinov AV; Lapin VA; Raĭt IuA
    Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation profile in systemic lupus erythematosus studies in 20 patients.
    Boey ML; Tsakok FH; Feng PH
    Singapore Med J; 1985; 26(4-5):361-4. PubMed ID: 4071090
    [No Abstract]   [Full Text] [Related]  

  • 29. [Modification of systemic lupus erythematosus in connection with steroid hormone therapy (clinico-morphological parallels)].
    Vinogradova OM; Potekseva MA
    Sov Med; 1966 Aug; 29(8):25-33. PubMed ID: 5991389
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk factors of avascular necrosis of the femoral head in patients with systemic lupus erythematosus under high-dose corticosteroid therapy.
    Ono K; Tohjima T; Komazawa T
    Clin Orthop Relat Res; 1992 Apr; (277):89-97. PubMed ID: 1555361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibodies in systemic lupus erythematosus.
    Newman JH; Abel R; Blatt PM
    Del Med J; 1990 Jan; 62(1):735-40. PubMed ID: 2311786
    [No Abstract]   [Full Text] [Related]  

  • 32. Correlation between steroid myopathy and serum lactic dehydrogenase in systemic lupus erythematosus.
    Kanayama Y; Shiota K; Horiguchi T; Kato N; Ohe A; Inoue T
    Arch Intern Med; 1981 Aug; 141(9):1176-9. PubMed ID: 7259378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The prostaglandin-prostacyclin system and thrombocyte functions in patients with systemic lupus erythematosus].
    Pribytkov IuN; Poltyrev AS; Shilkina NP
    Ter Arkh; 1992; 64(12):44-8. PubMed ID: 1292132
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic lupus erythematosus: observations on long-term survivors of "suppressive" therapy of lupus nephritis with prednisolone.
    Mackay IR
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1211-7. PubMed ID: 4139686
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
    Nordmark G; Bengtsson C; Larsson A; Karlsson FA; Sturfelt G; Rönnblom L
    Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic manifestations of systemic lupus erythematosus.
    Jagadish TK; Kasthuri AS; Uberoi HS; Chopra A; Gupta MM; Dham SK; Bhalla IP; Kumaravelu S; Bhangui GR
    J Assoc Physicians India; 1990 May; 38(5):329-32. PubMed ID: 2387812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The coagulation abnormalities in systemic lupus erythematosus.
    Gonyea L; Herdman R; Bridges RA
    Thromb Diath Haemorrh; 1968 Dec; 20(3):457-64. PubMed ID: 4179647
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acquired coagulation inhibitors. 10 cases (author's transl)].
    Alexandre P; André E; Briquel ME; Labrude P; Streiff F
    Nouv Presse Med; 1980 Oct; 9(39):2901-4. PubMed ID: 7443421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in body composition after glucocorticoid therapy in patients with systemic lupus erythematosus.
    Mok CC; To CH; Ma KM
    Lupus; 2008 Nov; 17(11):1018-22. PubMed ID: 18852226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravascular blood coagulation and immune complex inflammation in patients with systemic lupus erythematosus].
    Nasonova VA; Saĭkovskaia TV
    Ter Arkh; 1985; 57(7):91-8. PubMed ID: 2931851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.